03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Women's health & gynaecology
Dr Léa Wenger
clinical neuroscientist, founder and CEO of Cambridge start-up Cyclana
press citations on 1 topic since 5 Mar 2026 · last quoted 28 May 2026
02 Quoted on · 1 of 29 topics
Dr Léa Wenger: key facts
- Kind of voice
- Academic
- Role
- clinical neuroscientist, founder and CEO of Cambridge start-up Cyclana
- Quoted on
- Women's health & gynaecology
- Tracked press citations
- 3
- Most recently quoted
- 28 May 2026
- First quoted
- 5 Mar 2026
04 The signal · where Dr Léa Wenger sits on women's health & gynaecology
Ranked 56= of 100 voices quoted in the press on women's health & gynaecology, level with 36 others on 3 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Dr Sue MannClinicianNational Clinical Director for Women's Health, NHS England43 - 2=
Dr Alison WrightClinicianPresident, Royal College of Obstetricians and Gynaecologists (RCOG)17 - 2=
Prof Ranee ThakarClinicianPresident (2022–2025), Royal College of Obstetricians and Gynaecologists; Consultant Obstetrician and Urogynaecologist, Royal College of Obstetricians and Gynaecologists (RCOG)17 - 56=Dr Ruth ThompsonClinicianGP heading the women's health hub service3
- 56=Dr Fiona LemmensAcademicdeputy medical director for NHS Cheshire and Merseyside3
- 56=Dr Léa WengerAcademicclinical neuroscientist, founder and CEO of Cambridge start-up Cyclana3
- 56=Professor Sir Frank AthertonAcademicformer chief medical officer for Wales3
- 56=Helen O'ConnellAcademicAustralian neurologist3
Showing the leaders and the ranks around 56=, of 100 voices · See every voice on the topic →
05 On the record · press
What Dr Léa Wenger has said
- businessweekly.co.uk1
- cam.ac.uk1
- pharmafile.com1
Where Dr Léa Wenger has been quoted
- 01Endometriosis study begins recruitment in UK hospitalspharmafile.com · 28 May 2026
- 02Cyclana Bio steers new endometriosis initiativebusinessweekly.co.uk · 19 May 2026
- 03Cambridge start-up to tackle endometriosiscam.ac.uk · 5 Mar 2026
Verbatim
“Our tissue-first methodology represents a promising alternative approach in drug discovery, allowing us to reveal shared underlying mechanisms between patients, closing the gap on drug discovery programmes focusing on intracellular mechanisms that have failed to generate optimal treatments”
“Our tissue-first methodology represents a promising alternative approach in drug discovery, allowing us to reveal shared underlying mechanisms between patients, closing the gap on drug discovery programmes focusing on intracellular mechanisms that have failed to generate optimal treatments.”
“Women's health is currently in an unusual position. I'd say half of investors still think it's a bit niche but the other half have really bought into it being the next frontier.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- AI Cytology and HPV Testing Compared in Large Cervical Screening StudyBioengineer.org
- More than 1,800 signatures back petition urging Welsh government to improve women's health careShropshire Star
- P53-assisted METTL14-mediated m⁶A modification of SLC7A11 drives ferroptosis and inflammation in polycystic ovary syndromeNature
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.